Invention Grant
- Patent Title: 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
- Patent Title (中): 2-氧代-1-吡咯烷基咪唑并噻二唑衍生物
-
Application No.: US13502546Application Date: 2010-10-21
-
Publication No.: US08822508B2Publication Date: 2014-09-02
- Inventor: Yannick Quesnel , Laurent Turet , Joël Mercier
- Applicant: Yannick Quesnel , Laurent Turet , Joël Mercier
- Applicant Address: BE Brussels
- Assignee: UCB Pharma, S.A.
- Current Assignee: UCB Pharma, S.A.
- Current Assignee Address: BE Brussels
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: EP09173912 20091023
- International Application: PCT/EP2010/006434 WO 20101021
- International Announcement: WO2011/047860 WO 20110428
- Main IPC: A61K31/433
- IPC: A61K31/433 ; C07D513/04
Abstract:
The present invention relates to 2-oxo-1-pyrrolidine imidazothiadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
Public/Granted literature
- US20120245208A1 2-Oxo-1-Pyrrolidinyl Imidazothiadiazole Derivatives Public/Granted day:2012-09-27
Information query
